My Experience with Oral Chemotherapy

by Pam Seijo, advocate & stage IV survivor Back in the early 2000’s, after 21 months of chemo, radiation and surgeries, my body was struggling with blood counts, nutrition and overall existence. My oncologist and surgeon wanted me on chemo, but Irinotecan was doing me…

Read Full Post

Drug Shortage Updates from ASHP

Some recent updates from the American Society of Health-Systems Pharmacists of interest to people with colon and rectal cancer: Fluorouracil (5-FU) as of 8/31/11: On back order from Teva, APP Pharmaceuticals, and Mylan Institutional.  Manufacturing delays at Teva appear to have caused increased demand from…

Read Full Post

Irinotecan Lots Recalled

APP Pharmaceuticals has voluntarily recalled five lots of irinotecan for injection. Some customers discovered small particles of foreign material in one lot of the irinotecan vials.  Further inspection found fungal microbes in the vials they sent back. It is unlikely that you as a patient…

Read Full Post

Stage III MSI High Colon Cancer May Benefit from Irinotecan

About 15 percent of people with stage III colon cancer may have fewer recurrences and better survival when they are treated with irinotecan. Although all stage III colon cancers don’t have an additional benefit when irinotecan is added to bolus 5-FU and leucovorin in a treatment…

Read Full Post

Colorectal Cancer News in Brief: April 24

C3 Advocate Verna Cox was featured in the Philadelphia Daily News yesterday, and there’s a link to her story as well as links to the winning entries in the Get Screened Video Contest. This week, we also report research showing that the elderly benefit from…

Read Full Post